High-dose influenza vaccination was found to be significantly more effective than standard dose vaccination in preventing influenza, emergency room visits, and hospital admissions for adverse outcomes related to influenza, according to study results presented at IDWeek 2022, held from October 19 to 23, in Washington, DC. Researchers conducted an updated systematic review and meta-analysis to…
MV140 is a sublingual vaccine of whole-cell inactivated bacteria that may be an alternative to frequent antibiotics for recurrent urinary tract infections.
Findings from an ongoing randomized, placebo-controlled, observer-blind phase 3 trial showed Spikevax was 93.2% effective at preventing COVID-19.
The UK study aimed to investigate SARS-CoV-2 transmission and viral load in vaccinated and unvaccinated people with mild Delta variant infection.
In a case series, SARS-CoV-2 antibody titers increased after the third dose in a third of patients who previously had no response to vaccination.
Polyethylene glycol (PEG) found in mRNA-based COVID vaccines, Pfizer and Moderna, have excluded patients due to risk of allergic reactions, including anaphylaxis; the recent approval of Janssen’s COVID-19 vaccine, which contains polysorbate, provides an alternative for this population.
